Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Indigo Diabetes Raises €7M in Investment

BioPhotonics
Mar 2017
GENTBRUGGE, Belgium — Silicon photonic startup Indigo Diabetes NV has closed a €7 million ($7.4 million) round of series A investment to support its development of an optical glucose monitor for diabetics.

Single-chip glucose sensor.
Single-chip glucose sensor. Courtesy of Indigo Diabetes NV.

The company aims to use research from Ghent University and the imec electronics development center to replace conventional finger-prick blood tests with an implantable optical device.

“Licensing a series of new technologies from globally recognized research institutions UGent and imec enables Indigo to enter the market with the first needle-free and calibration-free glucose sensor,” said Danaë Delbeke, founder of Indigo and member of the Photonics Research Group at Ghent.

Thuja Capital is the lead investor.

Indigo Diabetesglucose monitorEuropeBusinessBiophotonicsSensors & DetectorsRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.